CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Auna $62.1 million senior secured notes offering
We advised Auna on the offering
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Haleon $3.1 billion secondary placing of ordinary shares
The private placement included 617,553,920 ordinary shares
Owens & Minor $1 billion secured notes offering
The high-yield notes are due 2030
Insulet $419 million repurchases of convertible senior notes
We advised the agent on the transaction
Visen Pharmaceutical HK$783.3 million IPO
The shares are listed on the HKEX
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Integer Holdings $1 billion convertible senior notes offering
The 1.875% convertible senior notes are due 2030
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market